AnaptysBio Inc. (NASDAQ: ANAB) was started with a Buy rating and assigned a $115 price target (versus a $71.08 close) at SunTrust Robinson Humphrey.
Arcos Dorados Holdings Inc. (NYSE: ARCO) was down 4.9% at $9.70 on Tuesday. The operator of McDonald’s through Latin America was started as Buy with a $12 price target at HSBC.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) was up 2.5% at $20.22 on Tuesday. KeyBanc Capital Markets maintained its Underweight rating and lowered its target price down to $17 from $21.
Boot Barn Holdings Inc. (NYSE: BOOT) was raised to Overweight from Neutral at JPMorgan.
Bioverativ Inc. (NASDAQ: BIVV) was reiterated as Buy and with a $64 price target (versus a $54.39 close) at Argus.
CVR Refining L.P. (NYSE: CVRR) was down 2.1% at $11.65 on Wednesday morning after UBS downgraded its rating to Sell from Neutral. Its 52-week range is $6.70 to $13.21.
Foot Locker Inc. (NYSE: FL) was up 1.2% at $30.00 on Tuesday but was indicated back down 1.5% at $29.55 on Wednesday on analyst calls ahead of earnings. Wedbush reiterated its Outperform rating but lowered its target to $39 from 445. Canaccord Genuity has a Buy rating but lowered its target to $36 from $39.
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) was assumed with a Buy rating with a $23 target price (versus a $10.54 close) at H.C. Wainwright. This was down 1.6% on Tuesday, in a 52-week range of $7.48 to $14.63.
M/A-Com Technology Solutions Holdings Inc. (NASDAQ: MTSI) was maintained as Hold but the target price was cut to $35 from $43 at Stifel. Merrill Lynch downgraded it to Underperform from Neutral and lowered its price objective to $30 from $45 and said that demand uncertainty could persist.
Marathon Petroleum Corp. (NYSE: MPC) was downgraded to Neutral from Buy at UBS, but the price target was raised to $65 from $63.
Neovasc Inc. (NASDAQ: NVCN) was down 17% at $0.84 on Tuesday. Leerink Swann lowered its price target to $5 from $10.
Platform Specialty Products Corp. (NYSE: PAH) was reinstated as Neutral with a $12 target price at Credit Suisse.
Smart Sand Inc. (NASDAQ: SND) was downgraded to Hold from Buy but the price target was raised to $9 from $7 (versus an $8.42 close) at Jefferies.
Synacor Inc. (NASDAQ: SCOR) was down 7% at $2.30 on Tuesday. Canaccord Genuity lowered its target price to $5 from $6, while the firm Craig-Hallum lowered its target price to $3.50 from $4.00.
Tyson Foods Inc. (NYSE: TSN) was raised to Buy from Hold at Argus, with the firm noting its strong outlook and broader protein sales.
Tesaro Inc. (NASDAQ: TSRO) was raised to Outperform from Market Perform with a $121 price target (versus an $86.73 close) at Leerink Swann.
Urogen Pharma Ltd. (NASDAQ: URGN) was down 2.5% at $42.18 on Tuesday, and it had earnings on Tuesday as well. Raymond James downgraded it to Market Perform from Outperform, and Oppenheimer maintained its Outperform rating and raised its target to $51 from $32.
YY Inc. (NASDAQ: YY) was down 1.5% at $89.23 on Tuesday, and after earnings it was indicated up 1.2% at $90.30 on Wednesday. Benchmark Securities has a Buy rating and raised its target price to $127. Jefferies raised its rating to Buy from Hold and the target price was raised to $110 from $79. The 52-week range is $37.81 to $97.59.
Warren Buffett has released a big list of changes to the public equity holdings of Berkshire Hathaway.
Tuesday’s top analyst calls were seen in Coca-Cola, Deutsche Bank, General Electric, JD.com, Peabody Energy, Qualcomm, WisdomTree Investments and many more.